<DOC>
	<DOCNO>NCT02447198</DOCNO>
	<brief_summary>Legislation allow medical marijuana significant impact pediatric population Colorado . There many report different effect property 60 know cannabinoids find marijuana . The main exposure pediatrics involve use Cannabidiol ( CBD ) high- Tetrahydrocannibinol ( THC ) low-content hash oil child epilepsy . The reported benefit oil anticonvulsant property CBD without psychoactive component THC . Human study efficacy CBD epilepsy limit . The investigator ' specific aim follow : - Specific Aim 1 : Describe plasma pharmacokinetics Cannabidiol ( CBD ) , Tetrahydrocannibinol ( THC ) , respective metabolite pediatric patient epilepsy . - Specific Aim 2 : Describe plasma pharmacokinetics antiepileptic drug ( AEDs ) take conjunction CBD order evaluate drug interaction . - Specific Aim 3 : Describe parental perception efficacy CBD control epilepsy . The investigator recruit child parent currently use plan use CBD seizure disorder . This study NOT provide patient CBD . Consenting subject undergo number blood urine collection analyze describe pharmacokinetics possible drug interaction CBD pediatric epilepsy .</brief_summary>
	<brief_title>Cannabidiol ( CBD ) Pediatric Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Patients &gt; 1 month &lt; 18 year age use , plan use , orally administer CBD rich hash oil treatment epilepsy Parent/legal guardian accompany patient &gt; = 18 year age nonincarcerated . Patients without epilepsy/seizure disorder diagnose neurologist Have know abnormality liver ( AST , ALT , INR normal range ) , kidney function ( creatinine normal range ) Patient know pregnant time enrollment ( however , guardian may pregnant include survey completion ) Patient ward state Unable provide verification hash oil potency content</criteria>
	<gender>All</gender>
	<minimum_age>31 Days</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>